Savara (SVRA) Net Margin (2013 - 2020)

Savara (SVRA) reported Net Margin of 1374100.0% for Q4 2020, down 31696.94% quarter-over-quarter from 4321.48% in Q3 2020.

Savara (SVRA) Net Margin (2013 - 2020) Analysis & Trends

Savara (SVRA) has 5 years of Net Margin data on file, last reported at 1374100.0% in Q4 2020.

Net Margin for Q4 2020 came in at 1374100.0%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2022 was 4109700.0% (changed N/A YoY), and the FY2020 annual result was 19305.45%, changed N/A from the prior year.
Net Margin slipped to 1374100.0% in Q4 2020 per SVRA's latest filing, from 4321.48% in the prior quarter.
Over five years, Net Margin peaked at 13257.45% in Q2 2017 and troughed at 1374100.0% in Q4 2020.
A 3-year average of 229876.45% and a median of 4819.25% in 2020 frame the typical range for Net Margin.
On a YoY basis, Net Margin climbed as much as 1730977 bps in 2016 and fell as far as 1730977 bps in 2016.
A 3-year view of Net Margin shows it stood at 1508.75% in 2016, then soared by 979 bps to 13257.45% in 2017, then plunged by 10465 bps to 1374100.0% in 2020.
Business Quant data shows SVRA's Net Margin at 1374100.0% in Q4 2020, 4321.48% in Q3 2020, and 13257.45% in Q2 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Margin (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	-
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	0.82%
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	-
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	-
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	-
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	34.53%
9	Abivax	90.15 Bn	90.15 Bn	-	-
10	Savara	1.33 Bn	1.33 Bn	-	-

Download Data